EFPIA’s general position regarding the provision of non-promotional information on prescription medicines:
-
European citizens expect and deserve a modern and comprehensive EU information strategy that will truly benefit them and help to improve public health.
-
Access for all EU citizens and patients to non-promotional health and medicines information in their language must be improved. EFPIA does not consider Direct-to-Consumer Advertising as an appropriate model for Europe.
-
Access to high quality medicines information from multiple sources is needed, including from the pharmaceutical industry, respecting the highest quality standards. Information should be judged by its actual quality, not the source providing it.
-
Availability of, and access to high-quality medicines information in all languages via the internet must be enhanced, while recognising the need for non-electronic tools for parts of the population and for improving access to such tools.
-
Public Private Partnerships, involving a range of healthcare stakeholders, could be one part of a comprehensive strategy.
-
Legislative reform at EU level is needed with the primary goal of giving the same opportunities to all EU citizens, taking into account positive experiences gained at individual Member State level.
-
Self-regulatory schemes with efficient governance and enforcement procedures (including third party involvement) would be the most practical and beneficial way forward, provided that an adequate legislative frame is put in place allowing the provision of high quality information from multiple sources. This approach would help ensuring that information to patients on prevention, diagnosis, treatment and management of diseases meets the highest quality standards and provides the greatest benefits to patients.
|